Improved method for expansion of tumour-reactive T-lymphocytes for immunotherapy of patients with cancer

Details for Australian Patent Application No. 2006328943 (hide)

Owner SentoClone International AB

Inventors Thorn, Magnus; Winqvist, Ola

Agent FB Rice

Pub. Number AU-B-2006328943

PCT Pub. Number WO2007/071388

Priority PA 2005 01810 21.12.05 DK; 60/752,828 21.12.05 US

Filing date 20 December 2006

Wipo publication date 28 June 2007

Acceptance publication date 21 July 2011

International Classifications

C12N 5/078 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells from blood or from the immune system

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

C12N 5/0783 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - T cells

Event Publications

3 July 2008 PCT application entered the National Phase

  PCT publication WO2007/071388 Priority application(s): WO2007/071388

7 April 2011 Alteration of Name

  The name of the applicant has been altered to SentoClone International AB Amendments

21 July 2011 Application Accepted

  Published as AU-B-2006328943

17 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006328944-Method for treating disseminated cancer

2006328934-Pyrrolo [1,2-a]quinoxaline derivatives as adenosine A3 receptor modulators and uses thereof